雅本化學(300261.SZ):公司未來的農藥業務重心落在蘭州基地
格隆匯7月14日丨雅本化學(300261.SZ)近期在接待機構投資者調研時表示,公司未來的農藥業務主要集中在南通基地、濱海基地、蘭州基地和襄陽基地。
南通基地、濱海基地都是公司穩健運營多年的核心基地,其中南通基地是溴代吡唑酸和左乙拉西坦等產品的規模化生產廠家;濱海基地主要從事綠色農藥原藥製劑的研發、生產和銷售。襄陽基地是公司通過產業併購基金投資的協作工廠,主要從事農藥及醫藥中間體的商業化生產。
公司未來的農藥業務重心落在蘭州基地:公司目前正快速推進蘭州基地建設,設立有包括蘭州雅本精細化工有限公司、甘肅蘭沃科技有限公司、甘肅蘭農科技有限公司、蘭州雅本藥物創制科技有限公司等3個現代化生產基地及1個高端創新基地。蘭州基地的設立是公司“走出長三角、融入大西北、參與大西北開發”戰略的重要部分,公司將在蘭州基地佈局專利期的產品,同時也有市場化產品,更高效、及時地為客户提供高品質的產品和服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.